Literature DB >> 90118

Purification of measles virus with preservation of infectivity and antigenicity.

W J Bellini, A Trudgett, D E McFarlin.   

Abstract

Measles virus Edmonston strain was purified by ultrafiltration followed by two successive sedimentations through sucrose. Purified virus retained infectivity and, when used as an immunogen, elicited high titred antibody to measles antigens by conventional serology. The measles preparations were examined by SDS-PAGE followed by staining. In addition, following PAGE, the purity of these preparations was assessed immunochemically using antisera directed to measles and host cell antigens. The results of these studies demonstrate the utility of the purification method for the preparation of milligram quantities of relatively pure measles virus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90118     DOI: 10.1099/0022-1317-43-3-633

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

Review 1.  Downstream processing in the biotechnology industry.

Authors:  Manohar Kalyanpur
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Biosynthesis of measles virus hemagglutinin in persistently infected cells.

Authors:  W J Bellini; G D Silver; D E McFarlin
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE.

Authors:  A Trudgett; W J Bellini; E S Mingioli; D E McFarlin
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

4.  Human cellular immune response to measles virus polypeptides.

Authors:  J W Rose; W J Bellini; D E McFarlin; H F McFarland
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  Immune reactivity of the purified hemagglutinin of measles virus.

Authors:  W J Bellini; D E McFarlin; G D Silver; E S Mingioli; H F McFarland
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  A target site for template-based design of measles virus entry inhibitors.

Authors:  Richard K Plemper; Karl J Erlandson; Ami S Lakdawala; Aiming Sun; Andrew Prussia; Jutatip Boonsombat; Esin Aki-Sener; Ismail Yalcin; Ilkay Yildiz; Ozlem Temiz-Arpaci; Betul Tekiner; Dennis C Liotta; James P Snyder; Richard W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-31       Impact factor: 11.205

7.  Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus.

Authors:  J Gheuens; D E McFarlin; K W Rammohan; W J Bellini
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Immunochemical features of a case of progressive rubella panencephalitis.

Authors:  J S Wolinsky; M N Waxham; J L Hess; J J Townsend; J R Baringer
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

9.  Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue.

Authors:  K Suryanarayana; K Baczko; V ter Meulen; R R Wagner
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Tangential Flow Filtration for the Concentration of Oncolytic Measles Virus: The Influence of Filter Properties and the Cell Culture Medium.

Authors:  Daniel Loewe; Tanja A Grein; Hauke Dieken; Tobias Weidner; Denise Salzig; Peter Czermak
Journal:  Membranes (Basel)       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.